Melphalan exposure induces an interleukin-6 deficit in bone marrow stromal cells and osteoblasts

被引:10
|
作者
Rellick, Stephanie L. [2 ]
Piktel, Debbie [2 ]
Walton, Cheryl [2 ]
Hall, Brett [4 ]
Petros, William
Fortney, James E. [2 ]
Gencheva, Marieta
Denvir, Jim [5 ]
Hobbs, Gerald [5 ]
Craig, Michael
Gibson, Laura F. [1 ,2 ,3 ]
机构
[1] W Virginia Univ, Mary Babb Randolph Canc Ctr, Sch Med, Alexander B Osborn Hematopoiet Malignancy & Trans, Morgantown, WV 26506 USA
[2] W Virginia Univ, Canc Cell Biol Program, Morgantown, WV 26506 USA
[3] W Virginia Univ, Dept Microbiol Immunol & Cell Biol, Morgantown, WV 26506 USA
[4] Ohio State Univ, Coll Med, Columbus, OH 43210 USA
[5] W Virginia Univ, Dept Stat, Morgantown, WV 26506 USA
关键词
Interleukin-6; Melphalan; Bone marrow microenvironment; Osteoblast; Bone marrow stromal cell; HEMATOPOIETIC STEM-CELL; MULTIPLE-MYELOMA; GROWTH-FACTOR; EXPRESSION; ENDOTHELIUM; SECRETION; ADHESION; NICHES; LINES; MICE;
D O I
10.1016/j.cyto.2012.01.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bone marrow stromal cells (BMSC) and osteoblasts are critical components of the microenvironment that support hematopoietic recovery following bone marrow transplantation. Aggressive chemotherapy not only affects tumor cells, but also influences additional structural and functional components of the microenvironment. Successful reconstitution of hematopoiesis following stem cell or bone marrow transplantation after aggressive chemotherapy is dependent upon components of the microenvironment maintaining their supportive function. This includes secretion of soluble factors and expression of cellular adhesion molecules that impact on development of hematopoietic cells. In the current study, we investigated the effects of chemotherapy treatment on BMSC and human osteoblast (HOB) expression of interleukin-6 (IL-6) as one regulatory factor. IL-6 is a pleiotropic cytokine which has diverse effects on hematopoietic cell development. In the current study we demonstrate that exposure of BMSC or HOB to melphalan leads to decreases in IL-6 protein expression. Decreased IL-6 protein is the most pronounced following melphalan exposure compared to several other chemotherapeutic agents tested. We also observed that melphalan decreased IL-6 mRNA in both BMSC and HOB. Finally, using a model of BMSC or HOB co-cultured with myeloma cells exposed to melphalan, we observed that IL-6 protein was also decreased, consistent with treatment of adherent cells alone. Collectively, these observations are of dual significance. First, suggesting that chemotherapy induced IL-6 deficits in the bone marrow occur which may result in defective hematopoietic support of early progenitor cells. In contrast, the decrease in IL-6 protein may be a beneficial mechanism by which melphalan acts as a valuable therapeutic agent for treatment of multiple myeloma, where IL-6 present in the bone marrow acts as a proliferative factor and contributes to disease progression. Taken together, these data emphasize the responsiveness of the microenvironment to diverse stress that is important to consider in therapeutic settings. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:245 / 252
页数:8
相关论文
共 50 条
  • [1] Alcohol induces interleukin-6 secretion from primary human osteoblasts and bone marrow stromal cells in vitro.
    Lin, D
    Zhang, J
    Dai, J
    Keller, ET
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S493 - S493
  • [2] Chemotherapy treatment induces an Interleukin-6 deficit in the bone marrow microenvironment
    Rellick, Stephanie
    Piktel, Debra
    Walton, Cheryl
    O'Leary, Heather
    Othumpangat, Sreekumar
    Hall, Brett
    Craig, Michael
    Gibson, Laura F.
    CANCER RESEARCH, 2010, 70
  • [3] REGULATION OF INTERLEUKIN-6 EXPRESSION IN MURINE BONE-MARROW STROMAL CELLS
    GIMBLE, JM
    HUDSON, J
    HENTHORN, J
    HUA, XX
    BURSTEIN, SA
    EXPERIMENTAL HEMATOLOGY, 1991, 19 (10) : 1055 - 1060
  • [4] REGULATION OF INTERLEUKIN-6 IN MULTIPLE-MYELOMA AND BONE-MARROW STROMAL CELLS
    CHAUHAN, D
    UCHIYAMA, H
    URASHIMA, M
    YAMAMOTO, K
    ANDERSON, KC
    STEM CELLS, 1995, 13 : 35 - 39
  • [5] Interleukin-6 A bone marrow stromal cell paracrine signal that induces neuroendocrine differentiation and modulates autophagy in bone metastatic PCa cells
    Delk, Nikki A.
    Farach-Carson, Mary C.
    AUTOPHAGY, 2012, 8 (04) : 650 - 663
  • [6] STIMULATION OF INTERLEUKIN-6 PRODUCTION BY ENDOTHELIN IN RAT BONE-MARROW-DERIVED STROMAL CELLS
    AGUI, T
    XIN, XN
    CAI, YQ
    SAKAI, T
    MATSUMOTO, K
    BLOOD, 1994, 84 (08) : 2531 - 2538
  • [7] Parathyroid hormone induces interleukin-6 gene expression in bone stromal cells of young rats
    Chiba, S
    Un-No, M
    Neer, RM
    Okada, K
    Segre, GV
    Lee, K
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2002, 64 (07): : 641 - 644
  • [8] Extracellular sphingomyelinase induces interleukin-6 synthesis in osteoblasts
    Tokuda, H
    Kozawa, O
    Harada, A
    Uematsu, T
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1999, 72 (02) : 262 - 268
  • [9] Bone marrow stromal-derived interleukin-6 (IL-6) stimulates proliferation and survival of neuroblastoma cells in the bone marrow microenvironment
    Ara, Tasnim
    Seeger, Robert C.
    Russell, Heidi V.
    Declerck, Yves A.
    CANCER RESEARCH, 2006, 66 (08)
  • [10] BONE-MARROW NEUTROPHILIA AND SUPPRESSED BONE TURNOVER IN HUMAN INTERLEUKIN-6 TRANSGENIC MICE - A CELLULAR RELATIONSHIP AMONG HEMATOPOIETIC-CELLS, OSTEOBLASTS, AND OSTEOCLASTS MEDIATED BY STROMAL CELLS IN BONE-MARROW
    KITAMURA, H
    KAWATA, H
    TAKAHASHI, F
    HIGUCHI, Y
    FURUICHI, T
    OHKAWA, H
    AMERICAN JOURNAL OF PATHOLOGY, 1995, 147 (06): : 1682 - 1692